Bonviva General Information
Bonviva (generic name: ibandronic acid / ibandronate sodium; brand names include: Idrofos / Bondronat / Bonviva) is used to treat or prevent osteoporosis in women after menopause.
Bonviva is designed to decrease activity of the cells that cause bone loss after menopause, with just one tablet a month. Bonviva helps slow or stop the natural processes that dissolve bone tissue; it binds with and stays in your bones throughout the month.
In fact, Bonviva is clinically proven to not only maintain bone density, but actually works with your body to help reverse bone loss. In clinical studies, 9 out of 10 women had improved bone density after 1 year on Bonviva.
Bonviva may also help lower the chances of breaking bones (fractures).
Bonviva Recommendations
Follow the directions for using this medicine provided by your doctor. Take Bonviva exactly as directed.
Bonviva 150 mg tablets are taken once a month. Choose one date of the month (your Bonviva day) that you will remember and that best fits your schedule to take your Bonviva 150 mg tablet.
Take Bonviva first thing in the morning.
Wait at least 1 hour (60 minutes) before eating or drinking anything except plain water.
Swallow Bonviva whole (do not chew or suck) with at least 6 to 8 ounces (1 cup) of plain water.
Do not take Bonviva with mineral water, sparkling water, coffee, tea, milk, or juice.
Avoid taking any other oral medicine, including calcium, antacids, or vitamins, for at least 60 minutes after taking Bonviva.
Avoid lying down for at least 60 minutes after taking Bonviva to help decrease the risk of problems in the esophagus and stomach.
Bonviva Precautions
Tell your doctor before taking Bonviva, if:
you are allergic to any medicines;
you have low blood calcium or kidney problems;
you are pregnant or breast-feeding.
Bonviva Ingredients
Active ingredient: ibandronate sodium.